News
News
Pharma Pulse
Multimedia
Editorial Podcasts
Editorial Videos
Profiles in Medicine
Conferences
Conference Coverage
Conference Listing
Publications
Pharmaceutical Executive
Brand Insights
Resources
Content Engagement Hubs
E-Books
Events
Sponsored Podcasts
Sponsored Videos
Webcasts
Whitepapers
Subscribe
Choose Specialty
Corporate Communications
Corporate Communications
Corporate Communications
Corporate Communications
Corporate Communications
Direct-to-Consumer
Direct-to-Consumer
Direct-to-Consumer
Direct-to-Consumer
Emerging Biopharma
Emerging Biopharma
Emerging Biopharma
IR Licensing and Partnerships
IR Licensing and Partnerships
IR Licensing and Partnerships
Market Access
Market Access
Market Access
Market Access
Medical Affairs
Medical Affairs
Medical Affairs
Medical Affairs
Operations
Operations
Operations
Operations
Operations
Patient Engagement
Patient Engagement
Regulatory
Regulatory
Regulatory
Regulatory
Sales & Marketing
Sales & Marketing
Sales & Marketing
Sales & Marketing
Spotlight -
Pharmaceutical Executive APEX Awards
Latest Executive Roundtables
Choose Specialty
Corporate Communications
Corporate Communications
Corporate Communications
Corporate Communications
Corporate Communications
Direct-to-Consumer
Direct-to-Consumer
Direct-to-Consumer
Direct-to-Consumer
Emerging Biopharma
Emerging Biopharma
Emerging Biopharma
IR Licensing and Partnerships
IR Licensing and Partnerships
IR Licensing and Partnerships
Market Access
Market Access
Market Access
Market Access
Medical Affairs
Medical Affairs
Medical Affairs
Medical Affairs
Operations
Operations
Operations
Operations
Operations
Patient Engagement
Patient Engagement
Regulatory
Regulatory
Regulatory
Regulatory
Sales & Marketing
Sales & Marketing
Sales & Marketing
Sales & Marketing
Spotlight
News
Multimedia
Conferences
Publications
Brand Insights
Resources
Subscribe
Advertisement
Arvindh Balakrishnan
home
/
authors
/
arvindh-balakrishnan
Arvindh Balakrishnan is vice-president for the life-sciences industry at Oracle.
Articles
New content coming soon.
Latest Updated Articles
Published: June 19th 2024
| Updated: June 24th 2024
Utilizing Biomarkers to Develop First-in-Class Antibody Drug Conjugates to Treat Advanced Solid Tumors
Published: February 17th 2025
| Updated: February 19th 2025
At First Glance
Published: February 14th 2025
| Updated: February 19th 2025
Q&A: Gain Therapeutics CEO Discusses AI-Driven Drug Discovery, Strategic Growth Plans
Published: July 9th 2020
| Updated: February 19th 2025
Will the Industry Rise to the Occasion?
Published: June 1st 2020
| Updated: February 19th 2025
Vaccine “Hesitancy” Threatens COVID Immunization Efforts
Published: May 1st 2020
| Updated: February 19th 2025
Master the Science of Success